Genenta Science S.p.A. (GNTA) Form 6-K — Jul 1, 2026
Genenta Science held its Annual Shareholders' Meeting on June 29, 2026, approving the statutory financial statements for 2025 and appointing five directors, including re-appointed Chairman and CEO Pierluigi Paracchi. Shareholders authorized the repurchase of treasury shares up to 30% of the share capital for an 18-month period. The Extraordinary Shareholders' Meeting was adjourned to July 29 and 30, 2026, to facilitate further engagement regarding the company's strategic transition. The agenda for the rescheduled meeting includes a proposed corporate name change to Saentra Forge S.p.A., a share capital increase, and a reverse stock split.
Key figures
- Treasury Share Authorization Period
- 18 months
- Treasury Share Authorization Percent
- 30%
- Aggregate Annual Director Compensation
- €165,000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.